FDA: Recall of Ready-to-Eat foods sold in WA for Listeria outbreak, 10 hospitalized in CA, NV
Fresh & Ready Foods, LLC has issued a recall for Ready-to-Eat foods with the 'use by' dates from April 22, 2025 to May 19, 2025 for the following brand names:
Fresh & Ready Foods
City Point Market Fresh Food to Go
Fresh Take Crave Away
The U.S. Food and Drug Administration (FDA) is investigating a Listeria outbreak in several Ready-to-Eat foods sold in Washington State, the Administration said in a release.
10 people have been hospitalized in California and Nevada with Listeria linked to the recalled foods.
The products have been sold in Washington, Arizona, California, and Nevada in a variety of locations, including retailers and food service locations such as hospitals, hotels, convenience stores, airports, and airlines, according to the FDA.
The FDA says these products do not need additional cooking, including sandwiches and snack items.
In April, investigators for the Centers for Disease Control (CDC) and the FDA found Listeria in samples collected from Fresh & Ready Foods during a routine inspection.
The FDA says mild symptoms of Listeria could include fever, muscle aches, nausea, tiredness, vomiting, and diarrhea. More severe symptoms could include headache, stiff neck, confusion, loss of balance, and convulsions.
Pregnant women and newborns, as well as adults 65 or older or those with weakened immune systems, are at high risk of contracting Listeria, the FDA says.
You should contact your healthcare provider right away if you have symptoms of a Listeria infection.
For more information on the recall, visit fda.gov.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
25 minutes ago
- The Hill
Cassidy's Kennedy quagmire
The Big Story The Trump administration assured Sen. Bill Cassidy (R-La.) his support of Robert F. Kennedy Jr.'s confirmation would mean no attacks on vaccine confidence, yet recent actions suggest those promises meant more to one side than the other. © AP Cassidy, the chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, publicly wavered over Kennedy's confirmation, with the then-nominee's refusal to acknowledge the safety and efficacy of vaccines being a particular sticking point. By the end of Kennedy's second confirmation hearing, Cassidy acknowledged he was still 'struggling' with the nomination. He was won over by Trump administration officials, who promised the senator would have input on hiring decisions; that federal advisory boards would remain unscathed; existing vaccine safety systems would continue; and Kennedy would testify before the HELP panel quarterly. But Kennedy's tenure as Health and Human Services (HHS) secretary has already seen massive layoffs, controversial changes to the vaccine approval process and the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices being cleared out and replaced with Kennedy's allies. Louisiana State University department chair and political science professor Robert Hogan suggested Kennedy's moves won't necessarily hurt Cassidy in a GOP primary. Cassidy is up for reelection next year. 'You would think that that would hurt him electorally, but … I think ultimately, what could have hurt him is if he had stuck with his professional standards and the standards of the medical community' and spoken out against Kennedy, Hogan said. The Louisiana senator hasn't spoken on Kennedy's actions that seemingly fly in the face of their agreement, only saying that he is continuing to talk with the Trump Cabinet secretary. Cassidy faces a tough road to reelection. He was among the GOP senators who voted to convict Trump of an impeachment article accusing him of inciting the Jan. 6 Capitol riot. Former House member John Fleming (R) has launched a primary campaign against him. Hogan said Fleming is a formidable opponent. 'If it comes down to, they're equal on every other dimension except [Fleming] did not vote to impeach Trump? That's the message, I think that will come through very clear to Republican voters,' he said. Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel, Joseph Choi and Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads How policy will be impacting the health care sector this week and beyond: CDC: Average age of US moms giving birth rises to nearly 30 The average age of first-time mothers in the U.S. has risen to almost 30, according to a new report from the Centers for Disease Control and Prevention (CDC). New data published in a National Vitals and Statistics Report on Friday shows the mean age of mothers at first birth increased by 0.9 years between 2016 and 2023, rising from 26.6 years to 27.5. Asian women reported the largest increase in mean age at first birth … Axelrod on RFK Jr.'s vaccine moves: 'Genuine catastrophe in the making' Democratic political strategist David Axelrod on Friday condemned changes Health and Human Services Robert F. Kennedy Jr. made to a key vaccine advisory committee. Kennedy earlier this week fired all 17 members of the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) and replaced them with eight of his own picks, a significant downsizing for the independent, expert … FDA approves expanded use of Moderna's RSV shot, but uncertainty remains The Food and Drug Administration (FDA) expanded the approval of Moderna's RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from respiratory syncytial virus, the company said. The vaccine was previously only licensed for adults 60 years and older. 'RSV poses a serious health risk to adults with certain chronic conditions, and today's approval marks an important … In Other News Branch out with a different read: Prediabetes interventions at forefront of treatment: What to know The conversation around prediabetes has entered a new day for Americans. Earlier this week, the American College of Lifestyle Medicine published the first clinical practice guideline to prioritize lifestyle interventions in treating Type 2 diabetes and prediabetes. The guideline offers a comprehensive roadmap for clinicians to effectively incorporate therapeutic lifestyle behavior interventions as a mainstay of treatment, while … Around the Nation Local and state headlines on health care: What We're Reading Health news we've flagged from other outlets: What Others are Reading Most read stories on The Hill right now: Republicans lay groundwork for 'total tax cliff' at end of Trump's term Congressional Republicans are laying the groundwork for a tax cliff at the end of President Trump's term in office. While the conference is pushing … Read more Newsom becomes a fighter, and Democrats beyond California are cheering California Gov. Gavin Newsom (D) is meeting the moment, Democrats say. Amid the growing storm over the Trump administration's response to protests … Read more What People Think Opinions related to health submitted to The Hill: You're all caught up. See you next week! Thank you for signing up! Subscribe to more newsletters here
New York Times
25 minutes ago
- New York Times
Kennedy's New Vaccine Advisers Helped Lawyers Raise Doubts About Their Safety
Three of the new advisers appointed by Health Secretary Robert F. Kennedy Jr. to guide the government on immunization policy took part in lawsuits casting doubt on the safety or efficacy of vaccines, public records show. In dismissing all 17 members of an influential Centers for Disease Control and Prevention advisory panel on Monday, Mr. Kennedy cited what he said was a history of conflicts of interest that he claimed made those experts a 'rubber stamp' on approving vaccines. But adding members who assisted in legal cases that were either against vaccine makers or that suggested widespread vaccine-caused harm raises questions about a different form of potential bias. While the legal involvement of the three new panelists does not appear to violate the rules, critics of Mr. Kennedy said it created the appearance of a conflict. 'He's invoking the language of ethics and integrity to get rid of these experts and now is installing people who may have their own biases — that he apparently does not want to recognize,' said Kathleen Clark, a law professor and ethics expert at Washington University in St. Louis. One of Mr. Kennedy's appointees, Vicky Pebsworth, is a nurse who serves on the board of a nonprofit dedicated to raising awareness about vaccine injuries. She certified to a court that, in her professional opinion, a survey of families of unvaccinated children supported the hypothesis that a rise in the number of recommended childhood vaccines explained an epidemic of chronic disease. Mr. Kennedy has espoused the same theory. Another, Dr. Robert Malone, a physician and biochemist whose criticism of mRNA Covid-19 vaccines catapulted him into the spotlight during the pandemic, was a paid expert witness on behalf of company whistle-blowers who claimed that Merck, one of the nation's largest vaccine manufacturers, had covered up evidence casting doubt on the effectiveness of the mumps vaccine. Want all of The Times? Subscribe.
Yahoo
32 minutes ago
- Yahoo
Foundation CEO Provides Expert Testimony to U.S. Senate as Outside Witness on Vision Research Funding
Jason Menzo Urges Robust FY2026 Funding for National Eye Institute and Protection of Its Independent Status COLUMBIA, Md., June 13, 2025 /PRNewswire/ -- The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, today submitted written testimony to the U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies through its chief executive officer, Jason Menzo, who served as an expert outside witness. In the testimony, Menzo urged the Subcommittee to deliver robust and sustained funding for the National Eye Institute (NEI) in Fiscal Year 2026 and to preserve NEI's status as an independent institute within the National Institutes of Health (NIH). "NEI is the only federal institute dedicated exclusively to vision research," said Jason Menzo, CEO of the Foundation Fighting Blindness. "Its work is restoring sight, advancing precision medicine, and delivering hope to millions of Americans living with retinal diseases. Continued investment is critical to maintaining momentum and achieving breakthroughs for conditions that currently have no cure." The Foundation's testimony highlights how NEI-supported research has led to transformative discoveries, including the first FDA-approved gene therapy for an inherited disease, and emphasizes NEI's strategic role in public-private collaborations that accelerate treatment development. The Foundation Fighting Blindness and NEI have long shared a close, collaborative partnership to advance high-impact scientific discovery and bring new treatments to patients faster. Vision loss from diseases such as retinitis pigmentosa, macular degeneration, and Stargardt disease currently affects tens of millions and costs the U.S. economy an estimated $134.2 billion annually. The Foundation emphasized that inconsistent funding stalls clinical trials, closes labs, and risks losing top scientific talent—consequences that are difficult and costly to reverse. The testimony also noted that for every dollar invested in NIH-funded research, $2.56 in new economic activity is generated, making this one of the highest-return investments Congress can make. "We're not just talking about restoring sight—we're talking about protecting America's leadership in biomedical innovation and supporting economic growth in communities nationwide," added Menzo. The Foundation Fighting Blindness urges Congress to: Provide strong, sustained funding for NEI in the FY2026 Labor-HHS Appropriations bill; and Preserve NEI's status as an independent institute within NIH to ensure focused, strategic investment in vision science. The full testimony is available at About the Foundation Fighting BlindnessEstablished in 1971, the Foundation Fighting Blindness is the world's leading private source of funding for research on retinal degenerative diseases. The Foundation has raised over $954 million toward its mission to prevent, treat, and cure blinding diseases such as retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and more. Visit for more information. Media Contacts:Chris AdamsVice President, Marketing & CommunicationsCAdams@ 423-0585 View original content to download multimedia: SOURCE Foundation Fighting Blindness
